EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 35 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,511,385 | -5.7% | 1,440,724 | +2.7% | 0.00% | – |
| Q2 2023 | $12,208,171 | +196.8% | 1,403,238 | +0.3% | 0.00% | – |
| Q1 2023 | $4,113,157 | -15.8% | 1,399,033 | +0.2% | 0.00% | – |
| Q4 2022 | $4,884,552 | -55.8% | 1,395,586 | -0.2% | 0.00% | – |
| Q3 2022 | $11,061,000 | +3.7% | 1,398,488 | +3.2% | 0.00% | – |
| Q2 2022 | $10,666,000 | -28.8% | 1,355,318 | +9.9% | 0.00% | – |
| Q1 2022 | $14,979,000 | +2.9% | 1,232,801 | +3.7% | 0.00% | – |
| Q4 2021 | $14,553,000 | +27.9% | 1,188,970 | +8.8% | 0.00% | – |
| Q3 2021 | $11,382,000 | +16.5% | 1,092,306 | +0.6% | 0.00% | – |
| Q2 2021 | $9,766,000 | +6.3% | 1,086,329 | +20.1% | 0.00% | – |
| Q1 2021 | $9,190,000 | +334.1% | 904,439 | +181.1% | 0.00% | – |
| Q4 2020 | $2,117,000 | – | 321,703 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $50,920,000 | 12.31% |
| ACUTA CAPITAL PARTNERS, LLC | 307,944 | $3,742,000 | 1.75% |
| Samsara BioCapital, LLC | 480,000 | $5,832,000 | 1.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,909,407 | $35,349,000 | 1.08% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,666 | $2,256,000 | 0.93% |
| Altium Capital Management LP | 224,541 | $2,728,000 | 0.91% |
| RA Capital Management | 3,370,506 | $40,952,000 | 0.89% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 276,591 | $3,361,000 | 0.42% |
| MYDA Advisors LLC | 55,000 | $668,000 | 0.26% |
| Atom Investors LP | 40,855 | $496,000 | 0.23% |